✦ LIBER ✦

PCN13 REAL LIFE OUTCOMES IN 2ND LINE ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PILOT STUDY IN FRANCE AND GERMANY ANALYSING ERLOTINIB VERSUS CHEMOTHERAPY

✍ Scribed by A. Vergnenegre; D.F. Heigener; H.G. Bischoff; C. Chouaid; G. Taylor-Stokes; A. Roughley; S. Walzer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN8 REAL LIFE OUTCOMES IN 1ST LINE NON-

✍ H.G. Bischoff; C. Chouaid; A. Vergnenegre; D.F. Heigener; G. Taylor-Stokes; A. R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

P-207 Docetaxel and irinotecan as first

✍ Groth, Gesine; Reck, Martin; Wilke, Hansjochen; Büchele, Thomas; Schäfer, Klaus; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 421 KB

PCN94 HEALTH-RELATED QUALITY OF LIFE (HR

✍ C. Chouaid; H.G. Bischoff; A. Vergnenegre; D.F. Heigener; G. Taylor-Stokes; A. R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Phase 1b study results of IMO-2055, a no

✍ Smith, David A.; Conkling, Paul; Richards, Donald A.; Flores, Maria Regina C.; N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB